keyword
https://read.qxmd.com/read/38622462/differences-between-patients-with-heartburn-refractory-to-vonoprazan-and-those-refractory-to-proton-pump-inhibitors
#1
JOURNAL ARTICLE
Tomoaki Matsumura, Michiko Sonoda, Kenichiro Okimoto, Hang Viet Dao, Satsuki Takahashi, Naoki Akizue, Ryosuke Horio, Chihiro Goto, Akane Kurosugi, Tatsuya Kaneko, Yuki Ohta, Takashi Taida, Atsuko Kikuchi, Mai Fujie, Jun Kato, Naoya Kato
BACKGROUND: Vonoprazan, a potassium-competitive acid blocker, demonstrates more potent acid inhibition than proton pump inhibitors (PPIs). This study aimed to evaluate the effect of vonoprazan in patients with unproven gastroesophageal reflux disease (GERD) by comparing patients with vonoprazan-refractory heartburn with those with PPI-refractory heartburn. METHODS: This study included 104 consecutive patients with vonoprazan- or PPI-refractory heartburn (52 patients each), no erosive esophagitis on endoscopy and who underwent combined multichannel intraluminal impedance-pH (MII-pH) testing with vonoprazan/PPI discontinuation...
April 15, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38563118/analysis-of-the-correlation-between-dynamic-characteristics-and-symptoms-of-gastroesophageal-reflux-disease
#2
JOURNAL ARTICLE
Yan Tian, Weihao Zhang, Tingting Zhang, Lan Liu, Jianqiang Guo
OBJECTIVE: To investigate the esophageal motility characteristics of gastroesophageal reflux disease (GERD) and their relationship with symptoms. PATIENTS AND METHODS: We examined 101 patients diagnosed with GERD by endoscopy and divided them into 3 groups as follows: nonerosive reflux disease (NERD), reflux esophagitis, and Barrett esophagus. Esophageal high-resolution manometry and the GERD Questionnaire were used to investigate the characteristics of esophageal dynamics and symptoms...
April 2, 2024: Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
https://read.qxmd.com/read/38472346/-difficult-to-treat-chronic-rhinosinusitis-when-the%C3%A2-standard-treatment-is-not-effective-and-biologics-are-not-available
#3
REVIEW
Robert Böscke
BACKGROUND: In recent years, significant improvements have been made in the treatment options for uncontrolled chronic rhinosinusitis (CRS) refractory to standard medical and surgical therapy. This is the result of a better understanding of the pathophysiology and the resulting development of biologicals for CRS with nasal polyps (CRSwNP). However, biologics are not (yet) available for all patients in Europe. OBJECTIVE: Based on the session "Difficult-to-treat CRS, when biologics are not available" at the 29th Congress of the European Rhinologic Society (ERS) 2023 in Sofia, Bulgaria, the treatment options for uncontrolled CRS with the exclusion of biologics will be discussed...
April 2024: HNO
https://read.qxmd.com/read/38466409/-biologic-therapy-in-patients-with-severe-nsaid-exacerbated-respiratory-disease-and-previous-aspirin-desensitization-results-of-a-multicentric-study
#4
JOURNAL ARTICLE
Anna-Rebekka Staufenberg, Hanna K Frankenberger, Ulrike Förster-Ruhrmann, Franziska C Spahn, Ludger Klimek, Kai Fruth, Clemens Stihl, Christoph Matthias, Moritz Gröger, Jan Hagemann
BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type‑2 inflammatory disease of the upper airways, with severe impairment of quality of life. Persons affected by NSAID-exacerbated respiratory disease (NERD) usually present with highly dynamic recurrence of polyps and disease despite prior treatment with sinus surgeries, oral corticosteroids, and aspirin desensitization (ATAD). Biologic therapy has fundamentally changed the choice of therapeutic concept; however, limited data exist on subgroups such as NERD patients...
March 11, 2024: HNO
https://read.qxmd.com/read/38409556/-does-aspirin-therapy-after-desensitization-still-have-a-role-in-treatment-of-chronic-rhinosinusitis-with-nasal-polyposis-in-the-era-of-biologics
#5
REVIEW
F Klimek, U Förster-Ruhrmann, J Hagemann, M Cuevas, M Gröger, L Klimek
The prevalence of analgesic intolerance syndrome (AIS), internationally known as NSAID-exacerbated respiratory disease (NERD), is reported to be 0.5-5.7% in the general population. The disease often begins with nasal symptoms, which are later joined by chronic rhinosinusitis with nasal polyposis (CRSwNP), asthma, and respiratory hypersensitivity reactions following use of nonsteroidal anti-inflammatory drugs (NSAIDs). In the setting of chronic respiratory disease, the type 2 inflammatory endotype is predominant in approximately 80% of patients with CRSwNP, rendering biologics directed against interleukin (IL)-4, IL‑5, IL-13, and IgE of high clinical interest, particularly in patients with severe CRSwNP and NERD...
February 26, 2024: HNO
https://read.qxmd.com/read/38315171/blood-pressure-variability-no-longer-a-mascot-for-research-nerds
#6
JOURNAL ARTICLE
Gianfranco Parati, Alessandro Croce, Grzegorz Bilo
No abstract text is available yet for this article.
February 5, 2024: European Heart Journal
https://read.qxmd.com/read/38263507/a-systematic-review-and-meta-analysis-of-the-efficacy-of-vonoprazan-for-proton-pump-inhibitor-resistant-gastroesophageal-reflux-disease
#7
JOURNAL ARTICLE
Daniel Martin Simadibrata, Elvira Lesmana, Ronnie Fass
BACKGROUND AND AIM: Up to 40% of gastroesophageal reflux disease (GERD) patients experience inadequate symptom relief with a proton pump inhibitor (PPI), termed PPI-resistant or refractory GERD. Vonoprazan, a potassium-competitive acid blocker, has better efficacy than PPI in suppressing gastric acid secretion. This meta-analysis summarizes the efficacy and safety of vonoprazan for treating PPI-resistant GERD (both erosive esophagitis [EE] and non-erosive reflux disease [NERD]). METHODS: Four electronic databases (Medline, Embase, SCOPUS, and CENTRAL) were searched for studies indexed until August 1, 2023...
January 23, 2024: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/38258770/systematic-review-on-herbal-preparations-for-controlling-visceral-hypersensitivity-in-functional-gastrointestinal-disorders
#8
JOURNAL ARTICLE
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Faezeh Niazi Shahraki, Nadia Zandi, Benyamin Pazoki, Mohammad Hosein Farzaei, Mehdi Ghasemi, Mohammad Abdollahi, Amir Hossein Abdolghaffari
BACKGROUND: Visceral hypersensitivity (VH) is an overreaction of the gastrointestinal (GI) tract to various stimuli and is characterized by hyperalgesia and/or allodynia. VH contributes to the etiology of many GI dysfunctions, particularly irritable bowel syndrome (IBS). Although the exact mechanisms underlying VH are yet to be found, inflammation and oxidative stress, psychosocial factors, and sensorimotor alterations may play significant roles in it. OBJECTIVE: In this review, we provide an overview of VH and its pathophysiological function in GI disorders...
January 22, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38220051/effect-of-antihypertensive-treatment-on-the-quality-of-life-of-patients-with-chronic-rhinosinusitis-with-nasal-polyps
#9
JOURNAL ARTICLE
Juan Maza-Solano, Carmen Palma-Martínez, Daniel Martín-Jiménez, Serafín Sánchez-Gómez, Ramón Moreno-Luna, Christian Calvo-Henriquez, Hugo Galera-Ruiz
AIM: Nasal polyposis (CRSwNP) shares type 2 inflammation biomarkers with asthma, allergy or arterial hypertension (AH), including periostin, a predictive marker of severity and post-surgical recurrence of polyposis. Antihypertensives have been shown to decrease periostin expression. We set out to evaluate the effect of antihypertensives on the quality of life of patients with CRSwNP. MATERIALS AND METHODS: Retrospective study of 43 patients with CRSwNP and ah with at least 1 year of follow-up and antihypertensive treatment prescribed after the diagnosis of CRSwNP...
January 12, 2024: Acta otorrinolaringologica española
https://read.qxmd.com/read/38132186/association-between-mean-nocturnal-baseline-impedance-mnbi-and-post-reflux-swallow-induced-peristaltic-wave-index-pspw-in-gerd-patients
#10
JOURNAL ARTICLE
Elena Roxana Sararu, Razvan Peagu, Carmen Fierbinteanu-Braticevici
Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders in the world. Two parameters, mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave index (PSPW), have been recently proposed to help differentiate GERD phenotypes. Our study aimed to assess whether there is any correlation between the two parameters, while also taking a look at their ability to distinguish between GERD phenotypes. We recruited 81 patients who were divided into 4 groups based on their GERD phenotype: erosive reflux disease (ERD), non-erosive reflux disease (NERD), reflux hypersensitivity (RH), and functional heartburn (FH)...
December 5, 2023: Diagnostics
https://read.qxmd.com/read/38098488/identification-of-novel-immune-cell-signature-in-gastroesophageal-reflux-disease-altered-mucosal-mast-cells-and-dendritic-cell-profile
#11
JOURNAL ARTICLE
Ahsen Ustaoglu, Fatema Arif Daudali, Manfredi D'afflitto, Stephen Murtough, Chung Lee, Estefania Moreno, Diana C Blaydon, David P Kelsell, Daniel Sifrim, Philip Woodland, Madusha Peiris
INTRODUCTION: Heartburn pathogenesis in GERD remains incompletely understood. We aimed to identify differences in the immune cell signature and sensory mucosal markers between reflux phenotypes and healthy asymptomatic subjects. METHODS: Thirty-seven patients with heartburn symptoms were phenotyped endoscopically and with objective reflux studies into erosive reflux disease (ERD) (N=10), nonerosive reflux disease (NERD) (N=9), functional heartburn (FH) (N=9), and Barrett's esophagus (BO) (N=9)...
2023: Frontiers in Immunology
https://read.qxmd.com/read/38088584/ziverel-for-ppi-refractory-reflux-symptoms-efficacy-and-mechanisms-of-action-in-humans
#12
JOURNAL ARTICLE
Thijs Kuipers, Renske A B Oude Nijhuis, René M van den Wijngaard, Jac M Oors, André J P M Smout, Albert J Bredenoord
OBJECTIVES: It is thought that esophageal hypersensitivity in combination with an impaired mucosal barrier function contributes to PPI-resistant reflux symptoms. Ziverel, a bioadhesive agent that coats the esophageal wall, was shown to have a positive effect on reflux symptoms. However, the mechanisms of action are unclear. We aimed to assess the effect of Ziverel on esophageal sensitivity to acid and mucosal barrier function. METHODS: We performed a double-blind randomized placebo-controlled crossover trial in PPI-refractory patients with reflux symptoms...
December 13, 2023: Scandinavian Journal of Gastroenterology
https://read.qxmd.com/read/38041136/different-dosages-of-vonoprazan-for-gastroesophageal-reflux-disease-study-protocol-for-a-pragmatic-crossover-cluster-randomized-controlled-trial-with-patient-preference-arms
#13
JOURNAL ARTICLE
Dongke Wang, Dan Zhou, Xinghuang Liu, Zhiyue Xu, Tao Bai, Xiaohua Hou
BACKGROUND: Vonoprazan results in more potent acid suppression for gastroesophageal reflux disease (GERD) than proton pump inhibitors. It has only been approved for treating erosive esophagitis in China, but 30-40% of GERD patients cannot achieve the goal of treatment with vonoprazan 20 mg daily. This study aims to investigate whether vonoprazan could relieve the symptoms of Chinese patients with non-erosive reflux disease (NERD) and whether increased dosage or different times of dosing could increase the response rate of GERD...
December 1, 2023: Trials
https://read.qxmd.com/read/38039618/exploring-the-impact-of-inflammatory-endotypes-on-olfactory-function-and-quality-of-life-in-chronic-rhinosinusitis-patients
#14
JOURNAL ARTICLE
Nájla Nonis Zucoloto, Felipe Silva de Aguiar, Natália Medeiros Dias Lopes, Ellen Cristine Duarte Garcia, Fabrizio Ricci Romano, Thiago Freire Pinto Bezerra, Wilma Terezinha Anselmo Lima, Marco Aurélio Fornazieri
OBJECTIVES: The aim of this observational cross-sectional study was to determine the endotypic inflammatory pattern of a sample of patients with CRS in Brazil, correlate it with olfactory function, and evaluate the clinical severity of the disease. METHODS: In this cross-sectional study, 73 CRS patients were recruited. Patients were classified into type 2 and non-type 2 endotypic patterns based on IgE and eosinophilia levels. All subjects performed the University of Pennsylvania Smell Identification Test (UPSIT®) and responded to the Sino-Nasal Outcome Test (SNOT-22)...
November 20, 2023: Brazilian Journal of Otorhinolaryngology
https://read.qxmd.com/read/37986601/editorial-on-demand-vonoprazan-for-nerd-when-should-it-be-demanded
#15
EDITORIAL
Peter J Kahrilas
No abstract text is available yet for this article.
December 2023: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/37986593/editorial-on-demand-vonoprazan-for-nerd-when-should-it-be-demanded-authors-reply
#16
EDITORIAL
Ronnie Fass, David Armstrong
No abstract text is available yet for this article.
December 2023: Alimentary Pharmacology & Therapeutics
https://read.qxmd.com/read/37979941/study-of-gastroesophageal-reflux-interpretation-of-functional-tests-in-the-obese-patient
#17
JOURNAL ARTICLE
Elizabeth Barba Orozco, Alberto Ezquerra Duran
Overweight and obesity are a public health problem and in 1997 obesity was recognized as a global epidemic by the World Health Organization (WHO). Overweight and obesity affect almost 60% of adults and one in three children in Europe according to the most recent WHO report. Objectively, gastroesophageal reflux disease (GERD) is defined as the presence of characteristic esophageal mucosal damage assessed by endoscopy and/or the demonstra-tion of pathological acid exposure by reflux monitoring studies. The prevalence of GERD is increased in obese patients In overweight and obese patients, the clinical symptoms of GERD are especially present in the supine position and this correlates with more frequent episodes of nocturnal reflux in the 24-h pH monitoring, there is also an increase in the number of refluxes with content acid...
November 16, 2023: Cirugia española
https://read.qxmd.com/read/37890849/frequency-of-functional-esophageal-disorders-in-patients-with-refractory-reflux-symptoms-in-lima-peru
#18
JOURNAL ARTICLE
Luis Piza-Palacios, Mercedes Cárdenas-Oña, Ximena Vásquez-Ojeda, Carmen Alurralde, Edith Rosas, Frine Samalvides-Cuba, Jorge Espinoza-Ríos
Gastroesophageal reflux disease (GERD) is a clinical condition in which gastric reflux causes symptoms or damage to the esophageal mucosa. It is managed with proton pump inhibitors, however, up to 45% of patients with suspected GERD are refractory to treatment. It is necessary to establish a true GERD diagnosis by means of a digestive endoscopy, which does not show lesions in approximately 70% of patients. In this scenario, it is necessary to perform an esophageal pH-impedance measurement, a procedure that allows to determine whether exposure to gastric acid is pathological...
2023: Revista de Gastroenterología del Perú: órgano Oficial de la Sociedad de Gastroenterología del Perú
https://read.qxmd.com/read/37876257/-diagnosis-and-treatment-of-gastroesophageal-reflux-disease-at-the-primary-health-care-clinics-in-korea
#19
JOURNAL ARTICLE
Young Sun Kim, Dong Hoon Kang, Hyun Chul Park, Tae Hoon Oh, Yong Sik Kim
BACKGROUND/AIMS: The prevalence of GERD and treatment costs are continuously rising in Korea, and the importance of primary health care clinics where the most treatment of actual patients is conducted is increasing. In this study, the diagnosis of GERD, selection of therapeutic drugs, and treatment methods in primary health care clininics were investigated through a large-scale multi-dimensional surveys. METHODS: From January 2015 to December 2018, the study data of 18,010 patients with GERD were retrospectively investigated based on eletronic medical record at 542 primary health care clinics in Korea...
October 25, 2023: Korean Journal of Gastroenterology, Taehan Sohwagi Hakhoe Chi
https://read.qxmd.com/read/37843630/among-females-older-than-50%C3%A2-years-saliva-secretion-is-significantly-lower-in-non-erosive-reflux-disease-patients-than-in-healthy-controls
#20
JOURNAL ARTICLE
Yoshimasa Hoshikawa, Eri Momma, Mai Koeda, Tomohide Tanabe, Shintaro Hoshino, Noriyuki Kawami, Katsuhiko Iwakiri
BACKGROUND: Saliva secretion is significantly lower in patients with non-erosive reflux disease (NERD) than in healthy controls (HC). A previous study on HC showed that saliva secretion was lower in females than in males. Saliva secretion may be lower in female patients with NERD than in male patients. Therefore, the present study investigated sex differences in saliva secretion in patients with NERD. METHODS: Subjects older than 50 years were included in the present study and consisted of 20 male patients with NERD, 19 male HC, 25 female patients with NERD, and 23 female HC...
October 16, 2023: Esophagus: Official Journal of the Japan Esophageal Society
keyword
keyword
112763
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.